Combined therapy of interstitial cystitis with the device AELTIS-SYNCHRO-02-"YARILO"
- Authors: Kalinina SN1, Molchanov AV1, Rutskaya NS1
-
Affiliations:
- Issue: No 2 (2004)
- Pages: 20-23
- Section: Articles
- URL: https://journals.eco-vector.com/1728-2985/article/view/275029
- ID: 275029
Cite item
Full Text
Abstract
Multiple modality therapy of interstitial cystitis (1С) - the disease
characterized by nicturia, pelvic pains, imperative pollakiuria - is considered.
As 1С nature is not well known, its treatment remains empiric.
Among the underlying causes, most probable are autoimmune,
allergic, infectious, neurological, vascular. Therefore, the treatment
should be multi-modality. Most usable now is combined chemotherapy.
Perspective is also 1С treatment with medicines in combination
with physiotherapy (electromagnetolaser AELTIS-SYNCHRO-02-YAR1LO").
Endovesical electrophoresis can be also applied
characterized by nicturia, pelvic pains, imperative pollakiuria - is considered.
As 1С nature is not well known, its treatment remains empiric.
Among the underlying causes, most probable are autoimmune,
allergic, infectious, neurological, vascular. Therefore, the treatment
should be multi-modality. Most usable now is combined chemotherapy.
Perspective is also 1С treatment with medicines in combination
with physiotherapy (electromagnetolaser AELTIS-SYNCHRO-02-YAR1LO").
Endovesical electrophoresis can be also applied
References
- Kozioi J. A. Epidemiology of interstitial cystitis. Urol. Clin. N. Am. 1994; 21: 7-20.
- Curnan G. C., Speiier F. E., Nunter D. J. et ai. Epidemiology of interstitial cystitis: a population based study. J. Urol. (Baltimore) 1999; 161:549-552.
- Kusek J., Nyberg L. The epidemiology of interstitial cystitis: is it time to expend our definition? Urology 2001; 57: 95-99.
- Oravisto K. J. Interstitial cystitis as an autoimmune disease: a review. Eur. Urol. 1980; 6: 10-13.
- Parsons С. L., Lilly J., Stein P. Epithelial dysfunction in nonbacterial cystitis. J. Urol. (Baltimore) 1991; 145: 732-735.
- Warren J. W. Interstitial cystitis as an autoimmune disease. Urol. Clin. N. Am. 1994; 21: 31-39.
- Sant G. R., Theoharides Т. С. The role of the mast cell. Urol.Clin. N.Am. 1994; 27:41-53.
- Pang X., Marchand S., Sant G. R. et al. Increased number of substance P (SP)-positive nerve fibers associated with bladdermast cells in interstitial cystitis (IS). In: Proceedings of the 7- th ICA/NIDDK Scientific Workshop. Orlando; 1993. 15.
- Hohemfellner M., Nunes L., Schmidt R. A. et al. Interstitial cystitis: increased sympathetic innervation and related neuropeptide synthesis. J. Urol. (Baltimore) 1992; 147: 587-591.
- Keay S., Warren J. W. A hypothesis for the etiology of interstitial cystitis based upon inhibition of bladder epithelial repair. Med. Hypothes. 1998; 51: 79-83.
- Keay S., Zhang C., Shoenfeit J. et al. Sensitivity and specitivity of antiproliferative factor, heparin-binding factor and epidermal growth factor as unique markers for interstitial cystitis. Urology 2001; 57 (suppl. 6): 9-14.
- Тиктинский О. Л., Калинина С. Н., Мишанин Е. А. Электролазерная терапия на аппарате "Ярило" у больных хроническим хламидийным простатитом. Урол. и нефрол. 1997; 4: 25-29.
- Жаров В. П., Тиктинский О. Л., Калинина С. Н. Новое в физиотерапии урогенитальных инфекций. В кн.: Материалы Конференции "Актуальные вопросы медицинской реабилитации больных урогенитальными заболеваниями и сексуальными дисгармониями". Кисловодск; 2000. 56-58.
- Калинина С. Н., Тиктинский О. Л., Мишанин Е. А., Богданов К. Р. Лечение копулятивной дисфункции у больных хроническим инфекционным простатитом электролазерным методом после этиотропной антиинфекционной терапии. В кн.: Материалы X Российского съезда урологов. М.; 2002. 280-281.
Supplementary files
